Chongqing Zhifei Bio Products (300122) — Cash Flow Reinvestment Rate
Chongqing Zhifei Bio Products (300122) has a Cash Flow Reinvestment Rate of 0.14x as of September 2025, reinvesting CN¥202.94 Million (capex CN¥202.94 Million ) from operating cash flow of CN¥1.42 Billion. Check Chongqing Zhifei Bio Products (300122) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Chongqing Zhifei Bio Products Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Chongqing Zhifei Bio Products across 18 annual periods. Explore 300122 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Chongqing Zhifei Bio Products (2007–2025)
Year-by-year capital reinvestment analysis for Chongqing Zhifei Bio Products. For live market cap and broader valuation context, see 300122 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.12x | CN¥624.84 Million | CN¥5.17 Billion | CN¥619.19 Million | ▼ -48.5% |
| 2023 | 0.23x | CN¥2.11 Billion | CN¥9.00 Billion | CN¥1.13 Billion | ▼ -68.9% |
| 2022 | 0.75x | CN¥1.50 Billion | CN¥1.99 Billion | CN¥1.45 Billion | ▲ +220.3% |
| 2021 | 0.24x | CN¥2.00 Billion | CN¥8.51 Billion | CN¥1.93 Billion | ▼ -8.3% |
| 2020 | 0.26x | CN¥896.98 Million | CN¥3.50 Billion | CN¥826.98 Million | ▼ -43.7% |
| 2019 | 0.46x | CN¥622.93 Million | CN¥1.37 Billion | CN¥572.93 Million | ▼ -46.0% |
| 2018 | 0.84x | CN¥493.82 Million | CN¥585.59 Million | CN¥479.82 Million | ▼ -31.6% |
| 2017 | 1.23x | CN¥250.85 Million | CN¥203.61 Million | CN¥230.85 Million | ▼ -75.9% |
| 2016 | 5.11x | CN¥459.82 Million | CN¥89.95 Million | CN¥308.05 Million | ▲ +239.2% |
| 2015 | 1.51x | CN¥336.72 Million | CN¥223.45 Million | CN¥225.72 Million | ▼ -12.2% |
| 2014 | 1.72x | CN¥276.96 Million | CN¥161.39 Million | CN¥276.96 Million | ▲ +88.8% |
| 2013 | 0.91x | CN¥201.37 Million | CN¥221.58 Million | CN¥201.37 Million | ▼ -48.5% |
| 2012 | 1.76x | CN¥199.06 Million | CN¥112.89 Million | CN¥199.06 Million | ▲ +26.0% |
| 2011 | 1.40x | CN¥309.56 Million | CN¥221.25 Million | CN¥309.56 Million | ▲ +47.2% |
| 2010 | 0.95x | CN¥51.51 Million | CN¥54.19 Million | CN¥51.51 Million | ▲ +1586.9% |
| 2009 | 0.06x | CN¥11.87 Million | CN¥210.61 Million | CN¥11.87 Million | ▼ -77.8% |
| 2008 | 0.25x | CN¥35.89 Million | CN¥141.58 Million | CN¥35.89 Million | ▲ +14.3% |
| 2007 | 0.22x | CN¥24.76 Million | CN¥111.66 Million | CN¥24.76 Million | — |